Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-05-25FDA Approved: GLIPIZIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals, Inc.'s supplemental application for glipizide (generic).
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications [Phase 3]
A Phase 3 long-term trial evaluating nateglinide plus valsartan for prevention or delay of type 2 diabetes mellitus and cardiovascular compl…
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial evaluating a decision aid for statin use in patients with type 2 diabetes mellitus; the study is completed.
-
CLINICAL_TRIALS trial_result · 2011-05-20Clinical Trial Update: Effect of Bosentan on Endothelial Function in Patients With Type 2 Diabetes [Phase 2]
A Phase 2 clinical trial evaluated the effect of bosentan on endothelial function in patients with type 2 diabetes. The study status is comp…
-
CLINICAL_TRIALS trial_result · 2011-05-20Clinical Trial Update: Exercise Intensity and Type 2 Diabetics [NA]
This clinical trial update reports that a study on exercise intensity and type in individuals with type 2 diabetes has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-05-18FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly, reflecting a labeling or formulation update under the supplementa…
-
FDA approval · 2011-05-18FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva Pharmaceuticals USA, Inc.'s supplemental application for liraglutide.
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059) [Phase 1]
A Phase 1 clinical trial evaluated the mechanism of action of sitagliptin in patients with Type 2 diabetes mellitus, with results posted aft…
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating adding insulin detemir to a liraglutide and metformin regimen versus liraglutide and metformin alone in adults with…
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: The FLAVO Trial: Dietary Flavonoids and Cardiovascular Disease Risk Reduction in Postmenopausal Women With Type 2 Diabetes [NA]
The FLAVO trial, a completed study, evaluated whether dietary flavonoids can reduce cardiovascular disease risk in postmenopausal women with…
-
CLINICAL_TRIALS trial_result · 2011-05-12Clinical Trial Update: Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes [Phase 3]
Phase 3 results from the Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI-2D) trial evaluating revascularization …
-
CLINICAL_TRIALS trial_result · 2011-05-12Clinical Trial Update: Metabolic and Vascular Effects of Statins in Untreated Dyslipidemic Diabetic Patients [Phase 3]
A Phase 3 study evaluated the metabolic and vascular effects of statins in untreated patients with Type 2 diabetes and diabetic dyslipidemia…
-
CLINICAL_TRIALS research · 2011-05-12Clinical Trial Update: Gastric Bypass Versus Best Medical Treatment on Progression of Carotid-intima Media Thickness in Type 2 Diabetes Mellitus (T2DM) [Phase 2, Phase 3]
This clinical trial compares gastric bypass surgery versus best medical therapy to evaluate the progression of carotid intima-media thicknes…
-
CLINICAL_TRIALS trial_result · 2011-05-11Clinical Trial Update: Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise [Phase 3]
Phase 3 trial results for saxagliptin in adults with type 2 diabetes not controlled by diet and exercise have been completed. Results were p…
-
CLINICAL_TRIALS trial_result · 2011-05-11Clinical Trial Update: Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078) [Phase 3]
A Phase 3 trial shows adding sitagliptin (Januvia) to metformin improves glycemic control in patients not adequately controlled on metformin…
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial [Phase 3]
Phase 3 ORIENT trial studied olmesartan for reducing incidence of end-stage renal disease in adults with diabetic nephropathy; the study com…
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: The Effect of Alcohol on ABCA1 Expression and Lipid Metabolism [NA]
Clinical trial examining the effect of alcohol on ABCA1 expression and lipid metabolism in people with type 2 diabetes mellitus and heart di…
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: Compare the Effect of DPP-IV Inhibitor or TZD on Glycemic Variability and Oxidative Stress in Patient With 2 Diabetes [Phase 4]
Phase 4 clinical trial comparing a DPP-4 inhibitor with a thiazolidinedione to assess effects on glycemic variability and oxidative stress i…
-
CLINICAL_TRIALS trial_result · 2011-05-06Clinical Trial Update: Effects of 3 Months of Supervised Exercise Training [NA]
This clinical trial update covers the effects of 3 months of supervised exercise training on overweight/obesity and glucose intolerance, inc…
-
CLINICAL_TRIALS trial_result · 2011-05-05Clinical Trial Update: Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol. [Phase 4]
A Phase 4 randomized trial evaluated an insulin protocol for managing diabetes in emergency room patients.
-
CLINICAL_TRIALS trial_result · 2011-05-05Clinical Trial Update: The Application of Extremely Low Level Magnetic Fields as Adjunctive Treatment for Type II Diabetes [Phase 2]
Phase 2 trial evaluating adjunctive use of extremely low-level magnetic fields for type 2 diabetes was terminated.
-
CLINICAL_TRIALS trial_result · 2011-05-04Clinical Trial Update: Taking Action Together- A Diabetes Prevention Program [NA]
This entry notes the completion of a Diabetes Prevention Program sponsored by the University of California, Berkeley, focused on preventing …
-
FDA approval · 2011-05-02FDA Approved: TRADJENTA — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved Tradjenta (linagliptin) as a new treatment for type 2 diabetes, representing the original approval of this DPP-4 inhibitor.
-
CLINICAL_TRIALS trial_result · 2011-04-29Clinical Trial Update: Diamel in the Treatment of Type 2 Diabetic Patients Receiving Insulin Therapy [Phase 3]
A Phase 3 trial evaluating Diamel in Type 2 diabetes patients receiving insulin therapy has completed, with Catalysis SL listed as the spons…
-
CLINICAL_TRIALS research · 2011-04-29Clinical Trial Update: Copenhagen Obesity Risk Assessment Study [NA]
A completed observational study from the University of Copenhagen assessing obesity-related risk factors, including metabolic syndrome, abdo…